{"id":42284,"date":"2025-09-25T16:41:31","date_gmt":"2025-09-25T08:41:31","guid":{"rendered":"https:\/\/flcube.com\/?p=42284"},"modified":"2025-09-25T16:41:32","modified_gmt":"2025-09-25T08:41:32","slug":"illumina-partners-with-pharma-giants-on-pan%e2%80%91cancer-companion-diagnostics-using-trusight-oncology","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42284","title":{"rendered":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology"},"content":{"rendered":"\n<p><strong>Illumina Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/ILMN:NASDAQ\">NASDAQ: ILMN<\/a>) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its <strong>TruSight Oncology (TSO) Comprehensive<\/strong> genomic platform.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-the-collaboration-brings\">What the Collaboration Brings<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Unified Genomic Profiling<\/strong> \u2013 The TSO Comprehensive test delivers a deep molecular profile of any solid tumor, pinpointing actionable genetic mutations that drive cancer growth.<\/li>\n\n\n\n<li><strong>Targeted Therapy Matching<\/strong> \u2013 Clinicians can use the companion diagnostic assays to confirm whether a patient is eligible for specific targeted drugs or clinical\u2011trial regimens, streamlining the precision\u2011medicine workflow.<\/li>\n\n\n\n<li><strong>Broad Cancer Coverage<\/strong> \u2013 By focusing on pan\u2011cancer biomarkers, the CDx panel supports treatment decisions across a wide array of tumor types, from breast and lung to colorectal and melanoma.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-why-it-matters\">Why It Matters<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Accelerated Precision Care<\/strong> \u2013 The partnership leverages Illumina\u2019s world\u2011class sequencing technology and the pharma partners\u2019 therapeutic pipelines, helping oncologists deliver the right drug to the right patient faster.<\/li>\n\n\n\n<li><strong>Regulatory Momentum<\/strong> \u2013 With the U.S. FDA\u2019s increasing focus on companion diagnostics, the TSO\u2011based CDx platform is positioned to meet emerging approval pathways and reimbursement frameworks.<\/li>\n\n\n\n<li><strong>Competitive Edge<\/strong> \u2013 The collaboration strengthens Illumina\u2019s portfolio in the rapidly expanding CDx market, positioning it against rivals such as Roche and Guardant Health.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-looking-ahead\">Looking Ahead<\/h3>\n\n\n\n<p>Illumina plans to launch the first set of CDx assays early in 2026, with subsequent expansions to include liquid\u2011biopsy capabilities and real\u2011time monitoring tools. The company\u2019s partners are already exploring integration with clinical\u2011trial data portals to enable adaptive trial designs based on real\u2011world genomic insights.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies&#8230;<\/p>\n","protected":false},"author":1,"featured_media":42287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[16,1639,109],"class_list":["post-42284","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cancer","tag-illumina","tag-precision-medicine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its TruSight Oncology (TSO) Comprehensive genomic platform.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42284\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology\" \/>\n<meta property=\"og:description\" content=\"Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its TruSight Oncology (TSO) Comprehensive genomic platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42284\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-25T08:41:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-25T08:41:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology\",\"datePublished\":\"2025-09-25T08:41:31+00:00\",\"dateModified\":\"2025-09-25T08:41:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284\"},\"wordCount\":274,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2515.webp\",\"keywords\":[\"Cancer\",\"Illumina\",\"Precision medicine\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42284#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42284\",\"name\":\"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2515.webp\",\"datePublished\":\"2025-09-25T08:41:31+00:00\",\"dateModified\":\"2025-09-25T08:41:32+00:00\",\"description\":\"Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its TruSight Oncology (TSO) Comprehensive genomic platform.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42284\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2515.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2515.webp\",\"width\":1080,\"height\":608,\"caption\":\"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42284#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology - Insight, China&#039;s Pharmaceutical Industry","description":"Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its TruSight Oncology (TSO) Comprehensive genomic platform.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42284","og_locale":"en_US","og_type":"article","og_title":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology","og_description":"Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its TruSight Oncology (TSO) Comprehensive genomic platform.","og_url":"https:\/\/flcube.com\/?p=42284","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-25T08:41:31+00:00","article_modified_time":"2025-09-25T08:41:32+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42284#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42284"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology","datePublished":"2025-09-25T08:41:31+00:00","dateModified":"2025-09-25T08:41:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42284"},"wordCount":274,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42284#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp","keywords":["Cancer","Illumina","Precision medicine"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42284#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42284","url":"https:\/\/flcube.com\/?p=42284","name":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42284#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42284#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp","datePublished":"2025-09-25T08:41:31+00:00","dateModified":"2025-09-25T08:41:32+00:00","description":"Illumina Inc. (NASDAQ: ILMN) announced a new alliance with a group of global pharmaceutical companies to develop a suite of pan\u2011cancer companion diagnostics (CDx) built on its TruSight Oncology (TSO) Comprehensive genomic platform.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42284#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42284"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42284#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp","width":1080,"height":608,"caption":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42284#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Illumina Partners with Pharma Giants on Pan\u2011Cancer Companion Diagnostics Using TruSight Oncology"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2515.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42284"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42284\/revisions"}],"predecessor-version":[{"id":42288,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42284\/revisions\/42288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42287"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}